Anne Minert

Dr. Anne Minert

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2010 in Genome Research
Verified
Journal Article
Open access
PDF file
JNJonathan Nissenbaum
Jonathan Nissenbaum
MDMarshall Devor
Marshall Devor
ZSZe'EV Seltzer
Ze'EV Seltzer
MGMathias Gebauer
Mathias Gebauer
MMMartin Michaelis
Martin Michaelis
ADAriel Darvasi
Ariel Darvasi
Chronic neuropathic pain is affected by specifics of the precipitating neural pathology, psychosocial factors, and by genetic predisposition. Little is known about the identity of predisposing genes. Using an integrative approach, we discovered that CACNG2 significantly affects susceptibility to chronic pain following nerve injury. CACNG2 encodes for stargazin, a protein intimately involved in the trafficking of glutamatergic AMPA receptors. The protein might also be a Ca2+ channel subunit. CACNG2 has previously been implicated in epilepsy. Initially, using two fine-mapping strategies in a mouse model (recombinant progeny testing [RPT] and recombinant inbred segregation test [RIST]), we mapped a pain-related quantitative trait locus (QTL) (Pain1) into a 4.2-Mb interval on chromosome 15. This interval includes 155 genes. Subsequently, bioinformatics and whole-genome microarray expression analysis were used to narrow the list of candidates and ultimately to pinpoint Cacng2 as a likely candidate. Analysis of stargazer mice, a Cacng2 hypomorphic mutant, provided electrophysiological and behavioral evidence for the gene's functional role in pain processing. Finally, we showed that human CACNG2 polymorphisms are associated with chronic pain in a cohort of cancer patients who underwent breast surgery. Our findings provide novel information on the genetic basis of neuropathic pain and new insights into pain physiology that may ultimately enable better treatments.

16 August 2017 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
AMAnne Minert
Anne Minert
SYShai-Lee Yatziv
Shai-Lee Yatziv
Marshall DevorMarshall Devor
Marshall Devor
The transition from wakefulness to general anesthesia is widely attributed to suppressive actions of anesthetic molecules distributed by the systemic circulation to the cerebral cortex (for amnesia and loss of consciousness) and to the spinal cord (for atonia and antinociception). An alternative hypothesis proposes that anesthetics act on one or more brainstem or diencephalic nuclei, with suppression of cortex and spinal cord mediated by dedicated axonal pathways. Previously, we documented induction of an anesthesia-like state in rats by microinjection of small amounts of GABAA-receptor agonists into an upper brainstem region named the mesopontine tegmental anesthesia area (MPTA). Correspondingly, lesioning this area rendered animals resistant to systemically delivered anesthetics. Here, using rats of both sexes, we applied a modified microinjection method that permitted localization of the anesthetic-sensitive neurons with much improved spatial resolution. Microinjected at the MPTA hotspot identified, exposure of 1900 or fewer neurons to muscimol was sufficient to sustain whole-body general anesthesia; microinjection as little as 0.5 mm off-target did not. The GABAergic anesthetics pentobarbital and propofol were also effective. The GABA-sensitive cell cluster is centered on a tegmental (reticular) field traversed by fibers of the superior cerebellar peduncle. It has no specific nuclear designation and has not previously been implicated in brain-state transitions.SIGNIFICANCE STATEMENTGeneral anesthesia permits pain-free surgery. Furthermore, because anesthetic agents have the unique ability to reversibly switch the brain from wakefulness to a state of unconsciousness, knowing how and where they work is a potential route to unraveling the neural mechanisms that underlie awareness itself. Using a novel method, we have located a small, and apparently one of a kind, cluster of neurons in the mesopontine tegmentum that are capable of effecting brain-state switching when exposed to GABAA-receptor agonists. This action appears to be mediated by a network of dedicated axonal pathways that project directly and/or indirectly to nearby arousal nuclei of the brainstem and to more distant targets in the forebrain and spinal cord.

1 December 2013 in Experimental Neurology
Verified
Journal Article
Closed access
ANAdi Nitzan-Luques
Adi Nitzan-Luques
AMAnne Minert
Anne Minert
MDMarshall Devor
Marshall Devor
MTMichael Tal
Michael Tal

1 January 2016 in Experimental Neurology
Verified
Journal Article
Closed access
AMAnne Minert
Anne Minert
Marshall DevorMarshall Devor
Marshall Devor

1 August 2007 in Experimental Neurology
Verified
Journal Article
Closed access
AMAnne Minert
Anne Minert
EGEran Gabay
Eran Gabay
CDCecilia Dominguez
Cecilia Dominguez
ZWZsuzsanna Wiesenfeld-Hallin
Zsuzsanna Wiesenfeld-Hallin
MDMarshall Devor
Marshall Devor

1 August 2007 in European Journal of Neuroscience
Verified
Journal Article
Closed access
MDMarshall Devor
Marshall Devor
AGAmit Gilad
Amit Gilad
MAMichal Arbilly
Michal Arbilly
JNJonathan Nissenbaum
Jonathan Nissenbaum
BYBenjamin Yakir
Benjamin Yakir
ADAriel Darvasi
Ariel Darvasi